“…Several studies have suggested that the up-regulation of TNFα, IL1β, IL6, and COX2 plays important roles in many inflammatory diseases including cytotoxicity in brain injuries and many neurodegenerative diseases such as AD, PD, and prion diseases [ 5 , 43 , 44 ]. Thus, many studies have been conducted to find their inhibitors [ 9 , 14 , 15 , 17 , 28 , 31 , 32 ]. Our results showed that APM reduced the expression of TNFα, IL1β, IL6, and COX2 by blocking their expression in LPS-stimulated BV2 and rat primary microglial cells.…”